Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Tyrer

Showing results (241-250 of 256) with videos related to

Pageof 26
Sort By:
Sexually Transmitted Infections|June 18, 2014
The clinical and cost-effectiveness of brief advice for excessive alcohol consumption among people attending sexual health clinics: a randomised controlled trialMike J Crawford, Rahil Sanatinia, Barbara Barrett, et al.
Personality and Mental Health|September 10, 2014
Preliminary studies of the ICD-11 classification of personality disorder in practicePeter Tyrer, Mike Crawford, Rahil Sanatinia, et al.
Lancet (London, England)|October 22, 2013
Clinical and cost-effectiveness of cognitive behaviour therapy for health anxiety in medical patients: a multicentre randomised controlled trialPeter Tyrer, Sylvia Cooper, Paul Salkovskis, et al.
Trials|July 19, 2015
Lamotrigine versus inert placebo in the treatment of borderline personality disorder: study protocol for a randomized controlled trial and economic evaluationMike J Crawford, Rahil Sanatinia, Barbara Barrett, et al.
BMC Psychiatry|August 31, 2010
The MATISSE study: a randomised trial of group art therapy for people with schizophreniaMike J Crawford, Helen Killaspy, Eleftheria Kalaitzaki, et al.
Molecular Cancer Therapeutics|February 7, 2024
ADCT-602, a Novel PBD Dimer-containing Antibody-Drug Conjugate for Treating CD22-positive Hematologic MalignanciesFrancesca Zammarchi, Karin E Havenith, Nikoleta Sachini, et al.
The American Journal of Psychiatry|April 7, 2018
The Clinical Effectiveness and Cost-Effectiveness of Lamotrigine in Borderline Personality Disorder: A Randomized Placebo-Controlled TrialMike J Crawford, Rahil Sanatinia, Barbara Barrett, et al.
Health Technology Assessment (Winchester, England)|April 14, 2018
Lamotrigine for people with borderline personality disorder: a RCTMike J Crawford, Rahil Sanatinia, Barbara Barrett, et al.
BMJ (Clinical Research Ed.)|March 1, 2012
Group art therapy as an adjunctive treatment for people with schizophrenia: multicentre pragmatic randomised trialMike J Crawford, Helen Killaspy, Thomas R E Barnes, et al.
BMC Psychology|November 25, 2015
Cognitive behaviour therapy for non-cardiac pain in the chest (COPIC): a multicentre randomized controlled trial with economic evaluationPeter Tyrer, Helen Tyrer, Sylvia Cooper, et al.
Pageof 26

Showing results (241-250 of 256) with videos related to

Sort By:
Pageof 26
Sexually Transmitted Infections|June 18, 2014
The clinical and cost-effectiveness of brief advice for excessive alcohol consumption among people attending sexual health clinics: a randomised controlled trialMike J Crawford, Rahil Sanatinia, Barbara Barrett, et al.
Personality and Mental Health|September 10, 2014
Preliminary studies of the ICD-11 classification of personality disorder in practicePeter Tyrer, Mike Crawford, Rahil Sanatinia, et al.
Lancet (London, England)|October 22, 2013
Clinical and cost-effectiveness of cognitive behaviour therapy for health anxiety in medical patients: a multicentre randomised controlled trialPeter Tyrer, Sylvia Cooper, Paul Salkovskis, et al.
Trials|July 19, 2015
Lamotrigine versus inert placebo in the treatment of borderline personality disorder: study protocol for a randomized controlled trial and economic evaluationMike J Crawford, Rahil Sanatinia, Barbara Barrett, et al.
BMC Psychiatry|August 31, 2010
The MATISSE study: a randomised trial of group art therapy for people with schizophreniaMike J Crawford, Helen Killaspy, Eleftheria Kalaitzaki, et al.
Molecular Cancer Therapeutics|February 7, 2024
ADCT-602, a Novel PBD Dimer-containing Antibody-Drug Conjugate for Treating CD22-positive Hematologic MalignanciesFrancesca Zammarchi, Karin E Havenith, Nikoleta Sachini, et al.
The American Journal of Psychiatry|April 7, 2018
The Clinical Effectiveness and Cost-Effectiveness of Lamotrigine in Borderline Personality Disorder: A Randomized Placebo-Controlled TrialMike J Crawford, Rahil Sanatinia, Barbara Barrett, et al.
Health Technology Assessment (Winchester, England)|April 14, 2018
Lamotrigine for people with borderline personality disorder: a RCTMike J Crawford, Rahil Sanatinia, Barbara Barrett, et al.
BMJ (Clinical Research Ed.)|March 1, 2012
Group art therapy as an adjunctive treatment for people with schizophrenia: multicentre pragmatic randomised trialMike J Crawford, Helen Killaspy, Thomas R E Barnes, et al.
BMC Psychology|November 25, 2015
Cognitive behaviour therapy for non-cardiac pain in the chest (COPIC): a multicentre randomized controlled trial with economic evaluationPeter Tyrer, Helen Tyrer, Sylvia Cooper, et al.
Pageof 26